Physician profile
Sidra Khalid
NPI 1518348978
$19,115.11
in general payments reported to CMS, 2019-2025
78 companies · $4,155 in 2025
The $4,155 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $509 · 2021: $2,757 · 2022: $3,153 · 2023: $3,930 · 2024: $4,611 · 2025: $4,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,514.61 |
| Education | $180.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,280.23 | 2020-2025 | Tecvayli, Darzalex, Erleada |
| Novartis Pharmaceuticals Corporation | $1,220.55 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $1,187.58 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Eisai INC. | $940.66 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $933.23 | 2020-2025 | Lynparza, Imfinzi, Calquence |
| Daiichi Sankyo INC. | $879.46 | 2020-2025 | Enhertu, Injectafer, Datroway |
| Incyte Corporation | $841.21 | 2021-2025 | Monjuvi, Jakafi, Pemazyre |
| E.R. Squibb & Sons, L.L.C. | $832.55 | 2020-2025 | Opdivo |
| Pfizer INC. | $661.38 | 2020-2025 | |
| Exelixis INC. | $631.97 | 2021-2025 | Cabometyx |
| Takeda Pharmaceuticals U.S.A., INC. | $523.00 | 2021-2025 | Ninlaro, Iclusig, Alunbrig |
| Lilly USA, LLC | $521.62 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Bayer Healthcare Pharmaceuticals INC. | $500.74 | 2020-2025 | |
| Celgene Corporation | $493.67 | 2022-2025 | Reblozyl, Pomalyst, Opdualag |
| Genzyme Corporation | $492.26 | 2020-2025 |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $476.64 | 2022-2025 | Trodelvy |
| Tersera Therapeutics LLC | $446.45 | 2021-2025 | Xermelo, Zoladex |
| Amgen INC. | $433.66 | 2020-2023 | Blincyto, Kyprolis, Lumakras |
| Stemline Therapeutics INC. | $362.65 | 2023-2025 | Orserdu |
| Genentech USA, INC. | $359.82 | 2022-2025 | Phesgo, Polivy, Tecentriq |
| Abbvie INC. | $318.66 | 2020-2025 | |
| Seagen INC. | $306.50 | 2020-2023 | Adcetris, Tukysa |
| Emd Serono, INC. | $265.88 | 2021-2025 | Bavencio, Tepmetko |
| Pharmaessentia USA Corporation | $260.78 | 2023-2025 | Besremi |
| Aveo Pharmaceuticals, INC. | $252.76 | 2022-2025 | |
| Glaxosmithkline, LLC. | $241.18 | 2021-2025 | Ojjaara, Zejula, Jemperli |
| Astellas Pharma US INC | $224.84 | 2023-2025 | Vyloy, Xospata, Padcev |
| Genmab U.S., INC. | $184.80 | 2023-2025 | Epkinly |
| Karyopharm Therapeutics INC. | $173.65 | 2020-2024 | Xpovio |
| Adc Therapeutics America, INC. | $172.17 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $153.38 | 2021-2025 | Libtayo |
| Ipsen Biopharmaceuticals, INC | $150.68 | 2021-2025 | Onivyde, Somatuline Depot |
| Alexion Pharmaceuticals, INC. | $150.52 | 2021-2025 | Ultomiris |
| Array Biopharma INC | $148.87 | 2024-2025 | Braftovi, Mektovi, Tukysa |
| Rigel Pharmaceuticals, INC. | $142.74 | 2021-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Pharmacyclics LLC, An Abbvie Company | $141.20 | 2020-2023 | Imbruvica |
| Beigene USA, INC. | $118.66 | 2021-2024 | Brukinsa |
| Puma Biotechnology, INC. | $103.94 | 2021-2025 | |
| Sobi, INC | $103.51 | 2022-2024 | |
| Pharmacosmos Therapeutics INC. | $93.36 | 2021-2024 | Monoferric |
| Jazz Pharmaceuticals INC. | $85.02 | 2024-2025 | |
| Acceleron Pharma, INC. | $81.18 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $77.60 | 2023-2025 | Yonsa, Odomzo |
| G1 Therapeutics, INC. | $71.99 | 2022-2023 | Cosela |
| Dendreon Pharmaceuticals LLC | $64.64 | 2024 | Provenge |
| Blueprint Medicines Corporation | $62.29 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.53 | 2025 | |
| Adaptive Biotechnologies Corporation | $61.37 | 2023-2025 | Clonoseq |
| Kyowa Kirin, INC. | $57.86 | 2021-2022 | |
| Taiho Oncology, INC. | $52.34 | 2022-2024 | |
| Geron Corporation | $48.16 | 2025 | Rytelo |
| Deciphera Pharmaceuticals INC. | $45.27 | 2022-2024 | Qinlock |
| Dova Pharmaceuticals | $44.79 | 2021 | |
| Mirati Therapeutics, INC. | $44.44 | 2023-2024 | Krazati |
| Syndax Pharmaceuticals, INC. | $43.95 | 2025 | |
| Morphosys, US INC. | $42.69 | 2021-2022 | |
| Servier Pharmaceuticals LLC | $38.70 | 2025 | |
| Myovant Sciences INC. | $33.55 | 2021-2022 | |
| Clovis Oncology, INC. | $32.73 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $30.12 | 2020-2021 | |
| Secura Bio, INC. | $23.84 | 2022 | |
| Apellis Pharmaceuticals, INC. | $22.43 | 2022 | |
| Allergan, INC. | $22.13 | 2020 | |
| Kite Pharma, INC. | $21.29 | 2024 | Yescarta |
| Springworks Therapeutics, INC. | $21.21 | 2025 | Ogsiveo |
| Caris Mpi, INC. | $20.06 | 2025 | Mi Cancer Seek |
| Recordati_rare_diseases_inc. | $19.66 | 2024 | Sylvant |
| Tg Therapeutics, INC. | $19.30 | 2021 | |
| Beone Medicines USA, INC. | $18.57 | 2025 | Brukinsa |
| Sanofi US Services INC. | $16.44 | 2025 | |
| Tactile Systems Technology INC | $15.82 | 2021 | |
| Veracyte, INC. | $15.33 | 2023 | |
| Apria Healthcare LLC | $14.34 | 2021 | |
| Spectrum Pharmaceuticals INC. | $14.13 | 2024 | Rolvedon |
| Medtronic, INC. | $13.02 | 2023 | Osteocool Rf Ablation System |
| Arbor Pharmaceuticals, INC. | $12.73 | 2021 | |
| Emmaus Medical, INC. | $12.37 | 2023 | Endari |
| Pharmaand Gmbh | $4.81 | 2025 | Rubraca |
Drugs and devices associated with these payments
Keytruda $707Opdivo $655Cabometyx $582Lenvima $539Enhertu $399Orserdu $363Lynparza $361Trodelvy $339Kisqali $310Reblozyl $304Epkinly $277Besremi $261Verzenio $254Jaypirca $249Monjuvi $243Tecvayli $235Tukysa $225Darzalex $209Xermelo $209Imbruvica $196Imfinzi $183Nubeqa $180Zoladex $178Fotivda $176Stivarga $173Retevmo $165Xtandi $152Jakafi $152Cablivi $151Erleada $145Ibrance $143Vitrakvi $141Phesgo $141Braftovi $135Ninlaro $135Welireg $133Adcetris $132Rybrevant $131Iclusig $130Pemazyre $129Scemblix $128Akeega $125Libtayo $123Mektovi $113Ultomiris $113Padcev $108Calquence $108Bosulif $105Elrexfio $101Balversa $96.52Venclexta $94.73Injectafer $91.31Alunbrig $91.02Pluvicto $90.12Ojjaara $89.35Fabhalta $88.61Zepzelca $85.02Zejula $84.78Jemperli $84.78Xpovio $82.96Polivy $80.97Talvey $78.14Odomzo $77.60Yonsa $77.60Tavalisse $71.93Rezlidhia $71.93Xofigo $69.94Doptelet $69.74Onivyde $66.86Lorbrena $66.62Talzenna $66.48Datroway $65.03Provenge $64.64Vyloy $64.58Bavencio $63.45Piqray $61.40Clonoseq $61.37Promacta $60.81Tecentriq $59.70Pomalyst $57.49Columvi $57.40Lunsumio $57.40Itovebi $54.26Fruzaqla $53.64Brukinsa $50.33Besponsa $50.30Orgovyx $49.65Enjaymo $48.20Rytelo $48.16Lutathera $48.13Xospata $47.52Oxbryta $47.19Mekinist $46.71Elahere $45.35Krazati $44.44Somatuline Depot $43.84Zynlonta $39.43Tibsovo $38.70Tasigna $38.38Comirnaty $38.28
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidra Khalid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.